ClinicalTrials.gov
public full text
Public Domain
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Randomized phase II clinical trial which aims to assess the impact on 3-month mortality and safety of adding adalimumab to standard treatment (anti-tuberculosis drugs and corticosteroids) in HIV patients with tuberculosis meningitis in 3 countries (Brazil, Mozambique, and Zambia).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis#844972
- Predictors of tuberculosis mortality among patients on treatment: A retrospective cohort study at a rural general hospital in Zambia#309460
- Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis#1363232
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness#900962
- Investigating gains in TB detection during rollout of Genexpert MTB/Rif universal access to drug susceptibility testing algorithm in Manicaland, Zimbabwe, 2017-2018#267524
Record · ID 1398417
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive